3-nitropropionic acid has been researched along with Idiopathic Parkinson Disease in 5 studies
3-nitropropionic acid: succinate dehydrogenase inactivator; biosynthesized by FABACEAE plants from ASPARAGINE
3-nitropropanoic acid : A C-nitro compound that is propanoic acid in which one of the methyl hydrogens has been replaced by a nitro group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the pathogenesis of Parkinson's disease and Huntington's disease excitotoxicity may play an important role." | 1.33 | Effects of mitochondrial toxins on the brain amino acid concentrations. ( Hartai, Z; Juhasz, G; Kekesi, KA; Klivenyi, P; Vecsei, L, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, L | 1 |
| Calingasan, NY | 1 |
| Wille, EJ | 1 |
| Cormier, K | 1 |
| Smith, K | 1 |
| Ferrante, RJ | 1 |
| Beal, MF | 1 |
| Sheline, CT | 1 |
| Zhu, J | 1 |
| Zhang, W | 1 |
| Shi, C | 1 |
| Cai, AL | 1 |
| Klivenyi, P | 1 |
| Kekesi, KA | 1 |
| Hartai, Z | 1 |
| Juhasz, G | 1 |
| Vecsei, L | 1 |
| Brouillet, E | 1 |
| Hantraye, P | 1 |
| Han, J | 1 |
| Cheng, FC | 1 |
| Yang, Z | 1 |
| Dryhurst, G | 1 |
1 review available for 3-nitropropionic acid and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antihypertensive Agents; Disease Models, Anim | 1995 |
4 other studies available for 3-nitropropionic acid and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 8-Hydroxy-2'-Deoxyguanosine; alpha-Synuclein; Analysis | 2009 |
Mitochondrial inhibitor models of Huntington's disease and Parkinson's disease induce zinc accumulation and are attenuated by inhibition of zinc neurotoxicity in vitro or in vivo.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carrier Proteins; Cation Transport Proteins; | 2013 |
Effects of mitochondrial toxins on the brain amino acid concentrations.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acids; Animals; Brain Chemistry; Cerebral Cortex | 2005 |
Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Corpus Striatum; | 1999 |